Northislet
VC Fund
Stockholm, Sweden
Northislet is a Nordic growth investor focused on investments in technology and life sciences. Northislet invests significantly in tiny growing enterprises where active ownership can increase long-term value. They select early-stage Tech and Life Science firms and use an active strategy, leveraging our skills and network, to assist in increasingthe total value of our investments.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Northislet invests in
Stages Northislet invests in
Countries Northislet invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Biopharma 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Funding Round 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies. | $681.9K / Seed / Oct 02, 2024 | |
|
|
BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells. | Sep 12, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Northislet invest in?
Northislet invests primarily in Biotechnology, Biopharma and Pharmaceutical startups, most often at Seed and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Northislet last invest?
The most recent investment recorded for Northislet closed in Oct 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!